CROHN'S DISEASE

This study is testing an investigational pill called zasocitinib for adults with active Crohn's disease. The main goals are to understand how the drug works at a cellular level in the gut and to check its safety. About 20 participants will take the drug for 12 weeks and undergo a…

This study aims to learn about the long-term safety and effectiveness of an investigational drug called balinatunfib for adults with Crohn's disease or ulcerative colitis. It will follow about 325 people who have already completed a previous 1-year study with this medication. The…

This study is testing whether adding a nutritional supplement called palmitoleic acid to the standard Crohn's disease medication infliximab helps heal the intestinal lining better than the medication alone. About 400 adults with active Crohn's disease will be randomly assigned to…

This study is testing a brief, one-day therapy workshop designed to help Veterans who have both inflammatory bowel disease (like Crohn's or colitis) and a mental health condition like depression or anxiety. The workshop uses acceptance and commitment therapy (ACT) to teach coping…

This study aims to see if using an ultrasound device helps medical staff place IV lines in children more quickly and with fewer needle sticks. It will observe 500 children under 18 who need an IV for outpatient procedures. Researchers will compare the time and number of attempts …

This study aims to compare the risk of serious infections in older adults (65+) with Ulcerative Colitis or Crohn's Disease when they start different advanced medications. It will look back at the medical records of about 23,900 people on Medicare from 2016 to 2025 to see if one t…